Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial

被引：0
|
作者：
Li, Shaohua [1 ]
Wei, Wei [1 ]
Wang, Qiaoxuan [1 ]
Guo, Zhixing [1 ]
Mei, Jie [1 ]
Lu, Lianghe [1 ]
Ling, Yihong [1 ]
Xu, Li [1 ]
Chen, Minshan [1 ]
Lin, Wenping [1 ]
Zou, Jingwen [1 ]
Wen, Yuhua [1 ]
Guo, Rongping [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
527
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial
    Wei, Wei
    Li, Shaohua
    Zhao, Rongce
    Cheng, Yuan
    Li, Qiang
    Lu, Lianghe
    Mei, Jie
    Shang, Changzhen
    Luo, Rui
    Pan, Mingxin
    Xiang, Bangde
    Jiang, Yuchuan
    Lei, Qiucheng
    Cao, Mingrong
    Li, Ji-Bin
    Zheng, Lie
    Chen, Huanwei
    Zhong, Jian-Hong
    Zhong, Chong
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [12] Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial
    Okusaka, T.
    Sato, T.
    Hinotsu, S.
    Shioyama, Y.
    Kasugai, H.
    Tanaka, K.
    Kudo, M.
    Saisho, T.
    Osaki, Y.
    Sata, M.
    Fujiyama, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [13] Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
    Okusaka, Takuji
    Kasugai, Hiroshi
    Shioyama, Yasukazu
    Tanaka, Katsuaki
    Kudo, Masatoshi
    Saisho, Hiromitsu
    Osaki, Yukio
    Sata, Michio
    Fujiyama, Shigetoshi
    Kumada, Takashi
    Sato, Keiko
    Yamamoto, Seiichiro
    Hinotsu, Shiro
    Sato, Tosiya
    JOURNAL OF HEPATOLOGY, 2009, 51 (06) : 1030 - 1036
  • [14] Phase III trial of transarterial chemotherapy in patients with unresectable hepatocellular carcinoma.
    Rudolph, KL
    Kubicka, S
    Chavan, A
    Kirchhoff, TD
    Layer, G
    Gallkowski, U
    Schmoll, E
    Galanski, U
    Manns, MP
    HEPATOLOGY, 1997, 26 (04) : 1857 - 1857
  • [15] Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma - A randomized controlled trial
    Lai, ECS
    Lo, CM
    Fan, ST
    Liu, CL
    Wong, J
    ARCHIVES OF SURGERY, 1998, 133 (02) : 183 - 188
  • [16] Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort
    Luo, Laihui
    Shan, Renfeng
    Cui, Lifeng
    Wu, Zhao
    Qian, Junlin
    Tu, Shuju
    Zhang, WenJian
    Xiong, Yuanpeng
    Lin, Wei
    Tang, Hongtao
    Zhang, Yang
    Zhu, Jisheng
    Huang, Zeyu
    Li, Zhigang
    Mao, Shengping
    Li, Hui
    Hu, Zemin
    Peng, Peng
    He, Kun
    Li, Yong
    Liu, Liping
    Shen, Wei
    He, Yongzhu
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, : 228 - 241
  • [17] Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
    Takada, T
    Amano, H
    Yasuda, H
    Nimura, Y
    Matsushiro, T
    Kato, H
    Nagakawa, T
    Nakayama, T
    CANCER, 2002, 95 (08) : 1685 - 1695
  • [18] Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
    Wang, Liming
    Wang, Weihu
    Rong, Weiqi
    Li, Zhuo
    Wu, Fan
    Liu, Yunhe
    Zheng, Yiling
    Zhang, Kai
    Siqin, Tana
    Liu, Mei
    Chen, Bo
    Wu, Jianxiong
    BMC CANCER, 2020, 20 (01)
  • [19] Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
    Liming Wang
    Weihu Wang
    Weiqi Rong
    Zhuo Li
    Fan Wu
    Yunhe Liu
    Yiling Zheng
    Kai Zhang
    Tana Siqin
    Mei Liu
    Bo Chen
    Jianxiong Wu
    BMC Cancer, 20
  • [20] Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis
    Wang, Lei
    Ke, Qiao
    Lin, Nanping
    Zeng, Yongyi
    Liu, Jingfeng
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (05) : 528 - 537
12345